SCHEMBL13321423

SCHEMBL13321423

O=C1O[C@@H]2C[C@@]1(O)C[C@H]1OC3(CCCC3)O[C@@H]21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13300885 1.00 — —
SCHEMBL14403629 0.98 — —
SCHEMBL10038584 0.98 — —
SCHEMBL9622125 0.98 — —
SCHEMBL9461132 0.98 — —
SCHEMBL13825702 0.98 — —
SCHEMBL13825709 0.80 MGAM (0.40) —
SCHEMBL10100000 0.80 MGAM (0.40) —
SCHEMBL10063791 0.80 MGAM (0.40) —
SCHEMBL16602936 0.80 MGAM (0.40) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8722725-B2 Caffeoylquinic acid derivatives containing nitrogen, and preparation method, pharmaceutical composition and usage thereof ZHEJIANG MEDICINE CO., LTD. XINCHANG PHARMACEUTICAL FACTORY (CN) 2014-05-13 — — US disclosed
US-20100144828-A1 CAFFEOYLQUINIC ACID DERIVATIVES CONTAINING NITROGEN, AND PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USAGE THEREOF ZHEJIANG MEDICINE CO., LTD. XINCHANG PHARMACEUTICA (CN) 2010-06-10 — — US disclosed
Send feedback